Tag : Pharma

Clinical Research, Pharma & Healthcare Financing

Adagio Medical Gets FDA IDE Approval for vCLAS® Ablation

Business Wire
by Business Wire019
Designed to Deliver Faster, More Efficient Ablation with Improved Usability on Established, Titratable, Endocardial-Approach ULTA Platform Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the...
Clinical Research, Pharma & Healthcare Financing

Assertio to Be Acquired by Garda Therapeutics

Business Wire
by Business Wire019
All-Cash Tender Offer of $18 per share – or $125.1 Million – Plus Contingent Value Right Tender Offer Price Represents 34.6% Premium to Unaffected Price...
Clinical Research, Pharma & Healthcare Financing

Cosette Pharma Expands Portfolio with SYMPAZAN® Acquisition

Business Wire
by Business Wire022
— Adds Portfolio of Branded Products with $48.9 million in 2025 Net Sales and an Established Commercial Presence — — SYMPAZAN® Establishes a Neurology Rare Disease Footprint...
Clinical Research, Pharma & Healthcare Financing

Resolve Therapeutics, Institut Pasteur Study Cell-Free RNA

PR Newswire
by PR Newswire023
Resolve Therapeutics and Institut Pasteur de Montevideo today announce a collaboration to use REJOIN-seq to identify the cell-free RNA (cfRNA) molecules that drive cytokine production...
Clinical Research, Pharma & Healthcare Financing

Unlock Health Book Highlights Financial Barriers to Care

PR Newswire
by PR Newswire023
The Price of Care: A Healthcare Leader’s Guide to Building Trust Through Health Insurance and Financial Literacy explores how providers can address the financial uncertainty shaping...
Clinical Research, Pharma & Healthcare Financing

Alzheon Doses First Subject in Phase 1 ALZ-507 Trial

Business Wire
by Business Wire027
ALZ-507 Designed as Well-Differentiated Oral Candidate Targeting Soluble Amyloid Oligomer Pathology, with Additional Mechanism of Action as APOE4 Corrector ALZ-507 IND Program Demonstrated Favorable Nonclinical...
Clinical Research, Pharma & Healthcare Financing

OneCyte and Kemp Proteins Partner to Boost Cell Line Development

PR Newswire
by PR Newswire030
OneCyte, a leader in high-throughput single-cell analysis and cell line development technologies, and Kemp Proteins, a pioneer in protein engineering and expression solutions, today announced...
Clinical Research, Pharma & Healthcare Financing

SirPAD Confirms Safety and Efficacy of Sirolimus Balloon

PR Newswire
by PR Newswire037
Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of the world’s largest randomised controlled trial of...
Clinical Research, Pharma & Healthcare Financing

IDEAYA Begins Phase 1 Trial of IDE574 for Multiple Tumors

PR Newswire
by PR Newswire044
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced that the first patient has been enrolled in its Phase 1 dose escalation...
Clinical Research, Pharma & Healthcare Financing

Aspect Biosystems $280M Partnership with Canada for Cell Medicines

Business Wire
by Business Wire049
Government investment will accelerate clinical development and strengthen Aspect’s advanced biomanufacturing capabilities for its bioengineered cellular medicines Aspect Biosystems, a biotechnology company pioneering a novel...
Clinical Research, Pharma & Healthcare Financing

Caliway Presents Preclinical Data on CBL-514 at ADA 2026

PR Newswire
by PR Newswire047
Caliway Biopharmaceuticals (TWSE: 6919), a clinical-stage biopharmaceutical company advancing innovative small-molecule therapies in aesthetic medicine, metabolic diseases, and other unmet medical needs, announced that the latest preclinical data on...
Clinical Research, Pharma & Healthcare Financing

Tanner Pharma & Biodexa Launch Global Early Access FAP

Business Wire
by Business Wire038
Tanner Pharma Group, a global provider of specialty medicine access solutions, and Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products...
Clinical Research, Pharma & Healthcare Financing

Sub-Q Bionics Closes $1.5M Pre-Seed for Lymphedema Care

Business Wire
by Business Wire030
Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5...
Clinical Research, Pharma & Healthcare Financing

Frontier Medicines Licenses FMC-220 with LG Chem

Business Wire
by Business Wire038
LG Chem will receive worldwide rights to FMC-220 outside of Greater China; Frontier will retain full ownership within Greater China Frontier will receive an upfront...
Clinical Research, Pharma & Healthcare Financing

Meiji Seika Pharma Invests in Centivax Universal Vaccine

Business Wire
by Business Wire041
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office:...